Objective: To compare the Tardieu Scale as a clinical measure of spasticity after stroke with the Ashworth Scale.
Design: Cross-sectional study.
Participants: Sixteen people, living in the community three years after their stroke.
Main measures: The Ashworth Scale and Tardieu Scale as well as laboratory measures of spasticity (stretch-induced electromyographic (EMG) activity) and contracture (maximum passive joint excursion) were collected from the affected elbow flexors and extensors and ankle plantarflexors and dorsiflexors by three examiners who were blinded to the results of the other measures.
Results: The percentage exact agreement (PEA) between the Tardieu Scale and a laboratory measure of spasticity was 100% for both the elbow flexors and ankle plantarflexors. This was significantly (P=0.02) greater than the PEA of 63% for both muscles between the Ashworth Scale and the same laboratory measure of spasticity. For contracture, the PEA between the Tardieu Scale and a laboratory measure was 94% for both the elbow flexors and the ankle plantarflexors. Pearson correlation coefficients between the Tardieu Scale and laboratory measures of spasticity were 0.86 for the elbow flexors and 0.62 for the ankle plantarflexors and between the Tardieu Scale and laboratory measures of contracture were 0.89 for the elbow flexors and 0.84 for the ankle plantarflexors.
Conclusion: In all cases that spasticity was overestimated by the Ashworth Scale, participants had a contracture. These findings suggest that the Tardieu Scale differentiates spasticity from contracture whereas the Ashworth Scale is confounded by it.
Get full access to this article
View all access options for this article.
References
1.
1 Lance JW. Symposium synopsis. In Feldman RG, Young RR, Koella WP eds. Spasticity: disordered motor control. Year Book Medical Publishers, 1980: 485–494.
2.
2 Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. The Practitioner1964; 192: 540–542.
3.
3 Bohannon RW, Smith M. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther1987; 67: 206–207.
4.
4 Van Wijck FM, Pandyan AD, Johnson GR, Barnes MP. Assessing motor deficits in neurological rehabilitation: patterns of instrument usage. Neurorehabil Neural Repair2001; 15:23–30.
5.
5 Pandyan A, Johnson G, Price C, Curless R, Barnes M, Rodgers H. A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil1999; 13: 373–383.
6.
6 Nielsen JF, Sinkjaer T. A comparison of clinical and laboratory measures of spasticity. Multiple Sclerosis1996; 1: 296–301.
7.
7 Priebe M, Sherwood A, Thornby J, Kharas N, Marlowski J. Clinical assessment of spasticity inspinal cord injury: a multidimensional problem. Arch Phys Med Rehabil1996; 77: 713–716.
8.
8 Vattanasilp W, Ada L. The relationship between clinical and laboratory measures of spasticity. Aust J Physiother1999; 45: 135–139.
9.
9 Vattanasilp W, Ada L, Crosbie J. Contribution of thixotropy, spasticity, and contracture to ankle stiffness after stroke. J Neurol Neurosurg Psychiatry2000; 69:34–39.
10.
10 Bakheit AMO, Maynard VA, Curnow J, Hudson N, Kodapala S. The relation between Ashworth scale scores and the excitability of the alpha motor neurones in patients with post-stroke muscle spasticity. J Neurol Neurosurg Psychiatry2003; 74: 646–648.
11.
11 Pandyan A, Price C, Barnes M, Johnson G. A biomechanical investigation into the validity of the modified Ashworth Scale as a measure of elbow spasticity. Clin Rehabil2003; 17: 290–293.
12.
12 Tardieu G, Shentoub S, Delarue R. A la recherché d'une technique de mesure de la spasticite. Rev Neurol1954; 91: 143–144.
13.
13 Tardieu G, Rondont O, Mensch J, Dalloz J-C, Monfraix C, Tabary J-C. Responses electromyographiques a l'etirement musculaire chez l'homme normal. Rev Neurol1957; 97:60–61.
14.
14 Held J, Pierrot-Deseilligny E. Reeducation motrice des affections neurologiques. J B Bailliere, 1969: 31–42.
15.
15 Gracies J-M, Marosszeky J, Renton R, Sandaman J, Gandevia S, Burke D. Short-term effects of dynamic lycra splints on upper limb in hemiplegia patients. Arch Phys Med Rehabil2000; 81: 1547–1555.
16.
16 Basmajan JV, Blumenstein R. Electrode placement in EMG biofeedback. Williams and Wilkins, 1980.
17.
17 Ibrahim IK, Berger W, Trippel M, Dietz V. Stretch-induced electromyographic activity and torque in spastic elbow muscles. Differential modulation of reflex activity in passive and active motor tasks. Brain1993; 116: 971–989.
20 Leslie GC, Muir K, Part NJ, Roberts RC. A comparison of the assessment of spasticity by the Wartenberg pendulum test and the Ashworth grading scale in patients with multiple sclerosis. Clin Rehabil1992; 6:41–48.
21.
21 Skold C, Harms-Ringdahl K, Hulting C, Levi R, Seiger A. Simultaneous Ashworth measurements and electromyographic recordings in tetraplegic patients. Arch Phys Med Rehabil1998; 79: 959–965.
22.
22 O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain1996; 119: 1737–1749.
23.
23 Hufschmidt A, Mauritz K-H. Chronic transformation of muscle in spasticity: a peripheral contribution to increased tone. J Neurol Neurosurg Psychiatry1985; 48: 676–685.
24.
24 Thilmann AF, Fellows SJ, Ross HF. Biomechanical changes at the ankle joint after stroke. J Neurol Neurosurg Psychiatry1991; 54: 134–139.
25.
25 Meyer M, Adorjani C. Tonic stretch reflex for quantification of pathological muscle tone. In Feldman RG, Young RR, Koella WP eds. Spasticity: disordered motor control. Symposia Specialists, 1980: 315–331.
26.
26 Ashby P, Burke D. Stretch reflexes in the upper limb of spastic man. J Neurol Neurosurg Psychiatry1971; 34: 765–771.
27.
27 Lehmann JF, Price R, deLateur BJ, Hinderer S, Traynor C. Spasticity: quantitative measurements as a basis for assessing effectiveness of therapeutic intervention. Arch Phys Med Rehabil1989; 70: 6–15.
28.
28 Ashby P, Mailis A, Hunter J. The evaluation of “spasticity”. Can J Neurol Sci1987; 14: 497–500.
29.
29 Lin J-P, Brown JK, Brotherstone R. Assessment of spasticity in hemiplegic cerebral palsy. II: distal lower-limb reflex excitability and function. Dev Med Child Neurol1994; 36: 290–303.
30.
30 Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy. Eur J Neurol1994; 6 (suppl 4): S23–S35.
